Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-29 Purchase(A) | 2024-04-09 7:08 pm | CG Oncology Inc. | CGON | Decheng Capital Global Life Sciences Fund IV L.P. Decheng Capital Management IV (Cayman) LLC Decheng Capital Global Healthcare Fund (Master) LP Decheng Capital Global Healthcare GP LLC Cui Xiangmin 10% Owner | 400,000 | $19 | $7,600,000 | 4,958,810 (Direct) | View |
| 2024-01-29 Purchase | 2024-01-31 4:30 pm | CG Oncology Inc. | CGON | Kasturi Vijay Chief Medical Officer | 1,315 | $19 | $24,985 | 1,315 (Direct) | View |
| 2024-01-29 Purchase | 2024-01-31 4:30 pm | CG Oncology Inc. | CGON | Roche Corleen M. CFO & Secretary | 2,000 | $19 | $38,000 | 2,000 (Direct) | View |
| 2024-01-29 Purchase | 2024-01-31 4:30 pm | CG Oncology Inc. | CGON | Song Hong Fang Director | 263,157 | $19 | $4,999,983 | 4,544,104 (Indirect Direct) | View |
| 2024-01-29 Purchase | 2024-01-31 4:17 pm | CG Oncology Inc. | CGON | Decheng Capital Global Life Sciences Fund IV L.P. Decheng Capital Management IV (Cayman) LLC Decheng Capital Global Healthcare Fund (Master) LP Decheng Capital Global Healthcare GP LLC Cui Xiangmin 10% Owner | 400,000 | $19 | $7,600,000 | 4,958,812 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-29 Conversion | 2024-01-31 4:30 pm | N/A N/A | CG Oncology Inc. | CGON | Song Hong Fang Director | 55,752,708 | $0 | 4,544,104 (Direct) | View |
| 2024-01-29 Conversion | 2024-01-31 4:17 pm | N/A N/A | CG Oncology Inc. | CGON | Decheng Capital Global Life Sciences Fund IV L.P. Decheng Capital Management IV (Cayman) LLC Decheng Capital Global Healthcare Fund (Master) LP Decheng Capital Global Healthcare GP LLC Cui Xiangmin 10% Owner | 38,223,094 | $0 | 4,958,812 (Direct) | View |
| 2024-01-24 Option Award | 2024-01-26 4:30 pm | N/A 2034-01-10 | CG Oncology Inc. | CGON | Roche Corleen M. CFO & Secretary | 492,920 | $0 | 492,920 (Direct) | View |
Ownership | 2024-01-24 9:11 pm | N/A 2032-05-25 | CG Oncology Inc. | CGON | Bellete Ambaw President and COO | 0 | $0 | 566,552 (Direct) | View |
Ownership | 2024-01-24 9:05 pm | N/A N/A | CG Oncology Inc. | CGON | Kuan Arthur Chief Executive Officer | 0 | $0 | 1,110,161 (Direct) | View |
Ownership | 2024-01-24 9:01 pm | N/A N/A | CG Oncology Inc. | CGON | Song Hong Fang Unique Diamond Investments Ltd Charming Jade Ltd ORI Healthcare Fund L.P. ORI Healthcare Fund II L.P. ORI Capital Inc. ORI Capital II Inc. ORI Capital Holding Inc. Healthcare Seed Ltd Director 10% Owner | 0 | $0 | 5,292,139 (Direct) | View |
Ownership | 2024-01-24 8:56 pm | N/A 2028-07-08 | CG Oncology Inc. | CGON | POST LEONARD E Director | 0 | $0 | 150,808 (Direct) | View |
Ownership | 2024-01-24 8:55 pm | N/A 2033-08-14 | CG Oncology Inc. | CGON | Kasturi Vijay Chief Medical Officer | 0 | $0 | 480,334 (Direct) | View |
Ownership | 2024-01-24 8:55 pm | N/A 2033-11-19 | CG Oncology Inc. | CGON | Graf Susan E Director | 0 | $0 | 104,876 (Direct) | View |
Ownership | 2024-01-24 8:47 pm | N/A 2028-07-08 | CG Oncology Inc. | CGON | Mulay James Director | 0 | $0 | 86,052 (Direct) | View |
Ownership | 2024-01-24 8:26 pm | N/A N/A | CG Oncology Inc. | CGON | Decheng Capital Global Life Sciences Fund IV L.P. Decheng Capital Management IV (Cayman) LLC Cui Xiangmin 10% Owner | 0 | $0 | 4,558,810 (Direct) | View |